Pfizer has agreed to buy an antibiotics business from AstraZeneca for $725m (€640m) as well as other payouts, settling for one piece of a company it once tried to acquire.

Drugs giant GlaxoSmithKline has raised around £425m from the sale of shares in South Africa’s Aspen Pharmacare.